Regeneron Pharmaceuticals, Inc.REGNNASDAQ
Loading
Free Cash Flow Growth Recovery in ProgressRecovering
Percentile Rank57
5Y CAGR+136.0%
Year-over-Year Change
Year-over-year free cash flow growth rate
5Y CAGR
+136.0%/yr
Long-term compound
Percentile
P57
Within normal range
vs 5Y Ago
73.2x
Strong expansion
Streak
3 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2025 | 11.35% |
| 2024 | -0.08% |
| 2023 | -17.11% |
| 2022 | -32.23% |
| 2021 | 225.90% |
| 2020 | 0.15% |
| 2019 | 10.40% |
| 2018 | 75.16% |
| 2017 | 6.21% |
| 2016 | 49.19% |